Evoke | Jotup

Evoke Announces Appointment of Group President Cris Morton

Retrieved on:

星期一, 十月 30, 2023

Health, HCP, Growth, AOR, Marketing, DTC, Management, Amici miei – Come tutto ebbe inizio, Evoke

NEW YORK, Oct. 30, 2023 /PRNewswire/ -- Evoke, an Inizio company and leading global life sciences brand, experience, and communications platform, announced today the appointment of Cris Morton as Group President, Marketing.

Key Points:

NEW YORK, Oct. 30, 2023 /PRNewswire/ -- Evoke, an Inizio company and leading global life sciences brand, experience, and communications platform, announced today the appointment of Cris Morton as Group President, Marketing.
"I am thrilled to have Cris join the leadership team at Evoke," said Reid Connolly, CEO & Founder of Evoke.
Cris joins Evoke most recently from Havas Health & You where he served as Group President for over 12 years and held numerous leadership roles prior with FCB Health and TBWA/World Health.
"I am so excited to be joining the Evoke team especially at this moment as there is real, palpable momentum," said Cris.

Evoke Announces Appointment of Group President Cris Morton

Retrieved on:

星期一, 十月 30, 2023

Health, HCP, Growth, AOR, Marketing, DTC, Management, Amici miei – Come tutto ebbe inizio, Evoke

NEW YORK, Oct. 30, 2023 /PRNewswire/ -- Evoke, an Inizio company and leading global life sciences brand, experience, and communications platform, announced today the appointment of Cris Morton as Group President, Marketing.

Key Points:

NEW YORK, Oct. 30, 2023 /PRNewswire/ -- Evoke, an Inizio company and leading global life sciences brand, experience, and communications platform, announced today the appointment of Cris Morton as Group President, Marketing.
"I am thrilled to have Cris join the leadership team at Evoke," said Reid Connolly, CEO & Founder of Evoke.
Cris joins Evoke most recently from Havas Health & You where he served as Group President for over 12 years and held numerous leadership roles prior with FCB Health and TBWA/World Health.
"I am so excited to be joining the Evoke team especially at this moment as there is real, palpable momentum," said Cris.

Evoke Pharma’s Abstract Entitled “Superiority of Nasal Spray Compared to Orally Administered Metoclopramide in Reducing Healthcare Costs in Treating Diabetic Gastroparesis Patients” to Be Presented at The American College of Gastroenterology (ACG) 2023 An

Retrieved on:

星期三, 十月 18, 2023

These new data build upon the findings presented in plenary session at Digestive Disease Week (DDW) earlier this year which demonstrated significant reductions in healthcare resource utilization (e.g., office, emergency department (ER) and hospital visits, etc.).

Key Points:

These new data build upon the findings presented in plenary session at Digestive Disease Week (DDW) earlier this year which demonstrated significant reductions in healthcare resource utilization (e.g., office, emergency department (ER) and hospital visits, etc.).
Upon identifying a major gap in gastroparesis treatment, Evoke developed GIMOTI as a nasal spray to specifically by-pass erratic absorption issues that DGP patients often suffer with medications that are in tablet or pill form.
Patients with long-standing diabetes can develop gastroparesis (a delay in stomach emptying).
“With the lack of effective oral treatments, and the promising findings for GIMOTI, Evoke is dedicated to make GIMOTI the standard of care for patients with diabetic gastroparesis,” said Dave Gonyer, R.Ph., Evoke Pharma CEO.

Evoke Neuroscience Elevates Cognitive Health with the Evoke EEG Brain Health System

Retrieved on:

星期一, 十月 23, 2023

NEW YORK, Oct. 23, 2023 /PRNewswire/ -- Evoke Neuroscience , a leading force in cognitive health, is proud to unveil its latest innovation, the Evoke EEG System with the world's largest human brain EEG and ERP database.

Key Points:

NEW YORK, Oct. 23, 2023 /PRNewswire/ -- Evoke Neuroscience , a leading force in cognitive health, is proud to unveil its latest innovation, the Evoke EEG System with the world's largest human brain EEG and ERP database.
Evoke Neuroscience , founded in 2009, has consistently demonstrated its commitment to pioneering advancements in cognitive health.
The Evoke EEG Brain Health System: A New Era
At the core of Evoke Neuroscience 's vision is the Evoke EEG System, a remarkable achievement in the field of cognitive health.
The Evoke EEG System is a testament to Evoke Neuroscience 's ongoing dedication to advancing cognitive health.

Industry leader Amar Urhekar joins Fishawack Health as Chief Operating Officer to integrate interdisciplinary teams across capabilities

Retrieved on:

星期二, 九月 12, 2023

Network, FH, The X Factor Digital Experience, Evoke, Creativity, Organization, Patient, Ashfield, Executive Committee, Global Media & Entertainment, Growth, Health, Management, Marketing, Policy

WASHINGTON, Sept. 12, 2023 /PRNewswire/ -- Fishawack Health (FH) announces it is expanding its executive leadership team with the addition of Amar Urhekar as its new Chief Operating Officer (COO), a pioneer in bringing together interdisciplinary teams to solve client challenges and accelerate growth.

Key Points:

WASHINGTON, Sept. 12, 2023 /PRNewswire/ -- Fishawack Health (FH) announces it is expanding its executive leadership team with the addition of Amar Urhekar as its new Chief Operating Officer (COO), a pioneer in bringing together interdisciplinary teams to solve client challenges and accelerate growth.
All business units — Consulting; Medical; Policy; Value, Evidence and Access; Marketing; and Digital Experience and Technology — will report to Urhekar.
"The challenges that face our industry are not siloed and neither should our creativity, strategies and mission to drive exceptional outcomes," said Fishawack Health CEO Jon Koch.
"It takes the right experience to see the connections and pinpoint solutions that drive lasting advancements in health.

KBRA Assigns Preliminary Ratings to FREMF 2023-K159 and Freddie Mac Structured Pass-Through Certificate Series K-159

Retrieved on:

星期二, 九月 5, 2023

Insurance, Professional Services, Probability, KBRA, SPCS, Federal takeover of Fannie Mae and Freddie Mac, Series, Freddie Mac, CMBS, NCF, Telescopic sight, Evoke

KBRA is pleased to announce the assignment of preliminary ratings to four classes of FREMF Series 2023-K159 mortgage pass-through certificates and three classes of Freddie-Mac structured pass-through certificates (SPCs), Series K-159.

Key Points:

KBRA is pleased to announce the assignment of preliminary ratings to four classes of FREMF Series 2023-K159 mortgage pass-through certificates and three classes of Freddie-Mac structured pass-through certificates (SPCs), Series K-159.
Freddie Mac will guarantee six classes of certificates issued in the underlying Series 2023-K159 securitization and will deposit the guaranteed underlying certificates into a separate trust that will issue the SPCs.
The underlying transaction is collateralized by 41 fixed-rate multifamily mortgage loans.
The assets are located in 17 states, with the three largest concentrations in Texas (20.9%), Florida (18.9%), and Missouri (10.3%).

Evoke launches audience intelligence offering to unlock full commercial potential of life sciences brands

Retrieved on:

星期二, 八月 15, 2023

Communication, Growth, CX, ROI, Evoke, Intelligence, Global health, HIV disease progression rates, Patient, KPI-driven code analysis, Marketing, Caregiver, Amici miei – Come tutto ebbe inizio

NEW YORK, Aug. 15, 2023 /PRNewswire/ -- Today, Evoke, an Inizio company and leading global health and life sciences brand, experience, and communications platform, unveiled its advanced audience intelligence offering, purpose-built for the needs of life sciences and pharma clients.

Key Points:

NEW YORK, Aug. 15, 2023 /PRNewswire/ -- Today, Evoke, an Inizio company and leading global health and life sciences brand, experience, and communications platform, unveiled its advanced audience intelligence offering, purpose-built for the needs of life sciences and pharma clients.
Evoke's audience intelligence offering is an omnichannel-ready, future-proofed solution that utilizes data with unmatched precision and provides critical insights on patients, caregivers, healthcare professionals, and payors.
The offering features four core solutions designed to reveal pain points and unlock commercial potential.
Affinitev™, Evoke's influencer identification and optimization offering, bridges the gap between life sciences companies, HCPs, and patients through influencer identification.

Evoke launches audience intelligence offering to unlock full commercial potential of life sciences brands

Retrieved on:

星期二, 八月 15, 2023

Communication, Growth, CX, ROI, Evoke, Intelligence, Global health, HIV disease progression rates, Patient, KPI-driven code analysis, Marketing, Caregiver, Amici miei – Come tutto ebbe inizio

NEW YORK, Aug. 15, 2023 /PRNewswire/ -- Today, Evoke, an Inizio company and leading global health and life sciences brand, experience, and communications platform, unveiled its advanced audience intelligence offering, purpose-built for the needs of life sciences and pharma clients.

Key Points:

NEW YORK, Aug. 15, 2023 /PRNewswire/ -- Today, Evoke, an Inizio company and leading global health and life sciences brand, experience, and communications platform, unveiled its advanced audience intelligence offering, purpose-built for the needs of life sciences and pharma clients.
Evoke's audience intelligence offering is an omnichannel-ready, future-proofed solution that utilizes data with unmatched precision and provides critical insights on patients, caregivers, healthcare professionals, and payors.
The offering features four core solutions designed to reveal pain points and unlock commercial potential.
Affinitev™, Evoke's influencer identification and optimization offering, bridges the gap between life sciences companies, HCPs, and patients through influencer identification.

Evoke Pharma and EVERSANA Announce Abstract Acceptance at 2023 American Neurogastroenterology and Motility Society (ANMS) Meeting

Retrieved on:

星期一, 八月 7, 2023

ER, University, Metoclopramide, Gastroenterology, Life, Health, Evoke, UCSD, University of California, San Diego Performance-Based Skills Assessment, Research, Gastroparesis, Associate, MD, Patient, Annual general meeting, FDA, GI, Pharmaceutical industry, Medicine

SOLANA BEACH, Calif. and CHICAGO, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI® (metoclopramide) nasal spray, and EVERSANA™, a leading provider of global commercial services to the life science industry, announced that its abstract entitled “Nasal Metoclopramide Reduces Healthcare Visits in Diabetic Gastroparesis Patients With and Without Prior Oral Metoclopramide History” will be presented in a poster session at the American Neurogastroenterology and Motility Society (ANMS) Annual Meeting being held August 11-13, 2023 in Austin, Texas.

Key Points:

in patients who either had prior treatment with oral metoclopramide or patients that were oral metoclopramide-naïve.
I am honored to bring these additional insights on the merits of nasal metoclopramide to the ANMS community.
As the first non-oral outpatient treatment for diabetic gastroparesis, GIMOTI presents a unique and effective option for patient care.
Further, EVERSANA Intouch has made a financial donation to IFFGD, on behalf Evoke and our GIMOTI collaboration.

Brandi Ascione Joins Underscore Marketing as EVP, Managing Director

Retrieved on:

星期二, 七月 18, 2023

Brandi Ascione has been appointed Executive Vice President (EVP), Managing Director at Underscore Marketing, joining an all-star team of life sciences innovators commercializing brands through data-driven audience activation.

Key Points:

Brandi Ascione has been appointed Executive Vice President (EVP), Managing Director at Underscore Marketing, joining an all-star team of life sciences innovators commercializing brands through data-driven audience activation.
In addition, her efforts in strategically scaling Evolution Road resulted in its recent sale to Evoke.
In her previous roles as a digital marketing change agent, Brandi focused on bringing new ideas to her clients to support both brand and customer objectives, satisfying their unique business challenges.
Brandi created and launched innovation-centric processes enabling her teams to identify the highest priority solutions for clients to best achieve their goals through digital dynamics.